Understanding how regulators of the actin cytoskeleton, like Flii, contribute to TLR signaling and inflammatory responses in autoimmune diseases like, EBA, may be important for development of novel therapeutics for autoimmune disease. This evidence concerns the gene FLII and autoimmune disease.